Skip to main content
Richard Boucher, MD, Pulmonology, Chapel Hill, NC, University of North Carolina Hospitals

RichardCBoucherMD

Pulmonology • Chapel Hill, NC

Pleural Disease

Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine

Join to view full profile

Dr. Boucher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Boucher's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1970 - 1972
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1970

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1978 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1985

Publications & Presentations

PubMed

Journal Articles

  • Roles of Mucus Adhesion and Cohesion in Cough Clearance  
    Elijah Lackey, Richard C Boucher, Michael Rubinstein, Proceedings of the National Academy of Sciences
  • Pathological Mucus and Impaired Mucus Clearance in Cystic Fibrosis Patients Results from Increased Concentration, Not Altered pH  
    Richard Boucher, MD, The European Respiratory Journal
  • Anaerobic Bacteria Cultured from CF Airways Correlate to Milder Disease-a Multisite Study  
    Marianne S Muhlebach, Peter H Gilligan, Richard C Boucher, The European Respiratory Journal

Press Mentions

  • Does Repeat COVID Infection Increase Risk of Severe or Long-Term COVID?
    Does Repeat COVID Infection Increase Risk of Severe or Long-Term COVID?February 16th, 2023
  • Do Repeat COVID Infections Increase the Risk of Severe Disease or Long COVID?
    Do Repeat COVID Infections Increase the Risk of Severe Disease or Long COVID?February 15th, 2023
  • Is Elevated Level of Lung Protein an Early Predictor for COPD?
    Is Elevated Level of Lung Protein an Early Predictor for COPD?May 28th, 2021
  • Join now to see all

Grant Support

  • Multidisciplinary Research Training In Pulmonary DiseasesNational Heart, Lung, And Blood Institute2012
  • The Role Of Anaerobic Bacterial Infection In Cystic FibrosisNational Heart, Lung, And Blood Institute2010–2012
  • Administrative CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2012
  • Molecular Therapy Core CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2012
  • Mucus Adhesion To Epithelial Cells And Its Mobilization In COPD And CFNational Heart, Lung, And Blood Institute2011
  • The Role Of Airway Surface Liquid Nucleotides/Nucleosides In Volume HomeostasisNational Heart, Lung, And Blood Institute2007–2011
  • AdministrativeNational Heart, Lung, And Blood Institute2007–2011
  • Pulmonary, Critical CARE, And Molecular TrainingNational Heart, Lung, And Blood Institute1995–2011
  • Pulmonary Epithelia In Health And DiseaseNational Heart, Lung, And Blood Institute1986–2011
  • Sccor In Host Factors In Chronic Lung DiseaseNational Heart, Lung, And Blood Institute2006–2010
  • Mucus Dehydration And Evolution Of COPD Lung DiseaseNational Heart, Lung, And Blood Institute2006–2010
  • Administrative And Biostatistics CoreNational Heart, Lung, And Blood Institute2006–2010
  • Clinical Trial: Mucus Clearance And Evolution Of COPD Lung DiseaseNational Center For Research Resources2008
  • The Biology Of Mucus And Mucus Plaques On CF AirwaysNational Heart, Lung, And Blood Institute2003–2007
  • SCOR In Airway Biology/Pathogenesis Of Cystic FibrosisNational Heart, Lung, And Blood Institute1998–2007
  • Pilot And Feasibility ProgramNational Institute Of Diabetes And Digestive And Kidney Diseases2006
  • Mucus Clearance In Acute COPD ExacerbationsNational Heart, Lung, And Blood Institute2005–2006
  • Endogenous Nucleotide Release In Airway DefenseNational Heart, Lung, And Blood Institute2001–2005
  • Administrative ComponentNational Institute Of Diabetes And Digestive And Kidney Diseases2004
  • Gene Therapy For Cystic FibrosisNational Heart, Lung, And Blood Institute1993–2003
  • Extracellular Barriers To Gene Transfer In The LungNational Heart, Lung, And Blood Institute2001–2002
  • Cell Biology Of Airway Epithelial Gene TransferNational Heart, Lung, And Blood Institute1999–2002
  • Role Of Airway Surface Liquid In Airway DefenseNational Heart, Lung, And Blood Institute1998–2002
  • Regulation Of Airway Mucosal Physiology/DefenseNational Heart, Lung, And Blood Institute1996–2000
  • Therapy For Cystic Fibrosis Lung DiseaseNational Heart, Lung, And Blood Institute1996–1997
  • Gene Transfer, Vector Safety, And Efficacy In MiceNational Heart, Lung, And Blood Institute1995–1997
  • AAV Transduction Of Differentiated Airway EpitheliumNational Heart, Lung, And Blood Institute1995–1997
  • SCOR In Cystic FibrosisNational Heart, Lung, And Blood Institute1993–1997
  • Regulation Of Ion Transport By Human Airway EpitheliaNational Heart, Lung, And Blood Institute1995
  • Core--Biomedical Engineering FacilityNational Heart, Lung, And Blood Institute1995
  • Cystic Fibrosis Research CenterNational Heart, Lung, And Blood Institute1988–1992
  • The Airway Mucosal BarrierNational Heart, Lung, And Blood Institute1985

Hospital Affiliations

Dr. Richard Boucher, Dr. Richard Boucher, MD, Dr. R Boucher, Dr. Richard C Boucher